LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling
Epigenomics · 2024
DOI: 10.1080/17501911.2024.2388018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epigenomics, 2024. Verfasst von Zhaohui Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Central Hospital of Yongzhou, Hunan Province, Yongzhou, 425000, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Janus Kinase 1, Signal Transduction, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific research project of Hunan Provincial Health and Family Planning Commission.
Abstract (Originalsprache)
Aim
To investigate function of somatostatin receptor 5 antisense RNA 1 (SSTR5-AS1) in esophageal carcinoma (ESCA).Materials & methods: The cellular function was assessed using EdU staining and Transwell assay. The localization of SSTR5-AS1 was measured using fluorescence in situ hybridization staining.
Results
SSTR5-AS1 shRNA repressed invasion and migration and induced apoptosis in ESCA cells. SSTR5-AS1 was distributed in cytoplasm, and it regulated its subunit integrin beta 6 (ITGB6) via eukaryotic translation initiation factor 4A3 (EIF4A3). SSTR5-AS1 shRNA inactivated ITGB6 and JAK1/STAT3 signaling. SSTR5-AS1 silencing attenuated the malignant behavior of ESCA cells through the ITGB6-mediated JAK1/STAT3 axis.
Conclusion
SSTR5-AS1 promotes tumorigenesis of ESCA by interacting with EIF4A3 to regulate ITGB6/JAK1/STAT3 axis, which serves a basis for discovering strategies against ESCA. The development of esophageal carcinoma (ESCA) seriously affects the health of people. Although great efforts have been made for curing ESCA, the outcomes remain limited. In this research, we used large amounts of experiments about the molecular biology. As expected, we found knockdown of lncRNA SSTR5-AS1 could inhibit the tumorigenesis of ESCA through mediation of its subunit integrin beta 6 /JAK1/STAT3 axis. Thus, our research provided new molecular targets for ESCA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Central Hospital of Yongzhou, Hunan Province, Yongzhou, 425000, China.
ORCID-Profile: Zhaohui Tang, Yongjun Jiang, Yuyu Zong, Sijuan Ding, Chen Wu, Zhangwen Tang, Lin Liao, Shaohui Jiang, Ruoting Tang, Fang Li, Pengfei Luo
Förderung
- Scientific research project of Hunan Provincial Health and Family Planning Commission
Zitieren
APA
Tang, Z., Jiang, Y., Zong, Y., Ding, S., Wu, C., Tang, Z., Liao, L., Jiang, S., Tang, R., Li, F., & Luo, P. (2024). LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling. Epigenomics. https://doi.org/10.1080/17501911.2024.2388018
Vancouver
Tang Z, Jiang Y, Zong Y, Ding S, Wu C, Tang Z, et al. LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling. Epigenomics. 2024. doi:10.1080/17501911.2024.2388018
BibTeX
@article{Tang2024,
author = {Tang, Zhaohui and Jiang, Yongjun and Zong, Yuyu and Ding, Sijuan and Wu, Chen and Tang, Zhangwen and Liao, Lin and Jiang, Shaohui and Tang, Ruoting and Li, Fang and Luo, Pengfei},
title = {LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling},
journal = {Epigenomics},
year = {2024},
doi = {10.1080/17501911.2024.2388018}
}
EUVIMED